• About
  • Technology
  • News3
  • About
  • Technology
  • News3
  • Disclaimer
  • Privacy statement

News

NEW
May 2023 - Both sites initiated for the upcoming Phase 1 clinical trial
May 2023

May 2023 - Both sites initiated for the upcoming Phase 1 clinical trial

NEW
May 2023 - First site initiated for the upcoming Phase 1 clinical trial
May 2023

May 2023 - First site initiated for the upcoming Phase 1 clinical trial

NEW
May 2023 - Jasper Steverink successfully defended PhD dissertation
May 2023

May 2023 - Jasper Steverink successfully defended PhD dissertation

April 2023 - SentryX Awarded €15.5M in EIC Accelerator Funding
April 2023

April 2023 - SentryX Awarded €15.5M in EIC Accelerator Funding

March 2023 - First patent officially granted in the United States
March 2023

March 2023 - First patent officially granted in the United States

February 2023 - SentryX Strengthens Clinical Operations Team
February 2023

February 2023 - SentryX Strengthens Clinical Operations Team

January 2023 - Green Light for SentryX's First Clinical Trial
January 2023

January 2023 - Green Light for SentryX's First Clinical Trial

December 2022 - First Clinical Trial Application Submitted
December 2022

December 2022 - First Clinical Trial Application Submitted

December 2022 - Future Outlook Robotic Surgery and BR-003
December 2022

December 2022 - Future Outlook Robotic Surgery and BR-003

October 2022 - Alex Vaccaro Joins SentryX Advisory Board
October 2022

October 2022 - Alex Vaccaro Joins SentryX Advisory Board

September 2022 - HTA-Modeling Collaboration Started
September 2022

September 2022 - HTA-Modeling Collaboration Started

September 2022 - Notice of Allowance for First Patent
September 2022

September 2022 - Notice of Allowance for First Patent

July 2022 - Publication of Hydrogel Technology
July 2022

July 2022 - Publication of Hydrogel Technology

April 2022 - Partner in KWF Research Grant
April 2022

April 2022 - Partner in KWF Research Grant

April 2021 - SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics
April 2022

April 2021 - SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics

February 2022 - FDA Takes New Steps to Stimulate Development of Non-Opioids in Acute Pain Management
February 2022

February 2022 - FDA Takes New Steps to Stimulate Development of Non-Opioids in Acute Pain Management

The new direction in pain treatment after surgery
  • Disclaimer
  • Privacy statement

SentryX Headquarters
Better-Meetings building
Woudenbergseweg 41
3711 AA Austerlitz
The Netherlands

info@sentryx.nl

SentryX Laboratory
Alexander Numan building
Yalelaan 54
3584 CM Utrecht
The Netherlands

Copyright © 2023 - SentryX